Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania
Recruiting now · Not applicable
Conditions studied: HIV Antiretroviral Therapy (ART) Adherence, PMTCT, Pregnancy, Retention in Care, HIV Viremia, Early Infant HIV Diagnosis
In brief
The goal of this clinical trial is to find better ways to care for pregnant and postpartum adolescent girls and young women (AGYW) aged 15-24 years with HIV in Tanzania, and to prevent them from passing HIV to their babies. The main questions it aims to answer are: * How often do young pregnant women with HIV go to their health appointments and stay on their treatment up to two years after giving birth? * How many babies born to young women with HIV stay HIV-free for two years? * How soon do young women with HIV get pregnant again after giving birth, and what factors affect this? * What are the best ways to help young women with HIV stay in care and stay healthy during and after pregnancy? * What social and structural factors affect whether young pregnant women with HIV go to their health appointments and stay on their treatment? * How can we work with young women with HIV to create and test a package of interventions to improve their healthcare during and after pregnancy? * Can this package of interventions help young women with HIV stay in care and remain healthy during and after pregnancy? Participants will: * Have their health data analyzed via health service records of all women who received HIV prevention services between 2018 and 2020, and were followed until 2023, across 559 health facilities in Tanzania. * Participate in qualitative interviews to share their experiences and challenges with staying in care. * Help to co-create a package of interventions to improve care. * Take part in a cluster-randomized trial to test these interventions. Researchers will compare the outcomes of the intervention package to see if they improve care engagement, retention, and health outcomes for AGYW with HIV during and after pregnancy.
Key facts
- Study ID
- NCT06605053
- Run by
- Karolinska Institutet
- People needed
- 222
- Starts
- 2024-10-07
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2025-06-29
Who can join
Age: 15 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Pregnant/postpartum adolescent girls and young women (AGYW) with HIV aged 15-24 years, who started PMTCT services between January 1, 2018, and December 31, 2020.
- Infants born to the included AGYW during this period.
You may not qualify if…
- AGYW whose ART (Antiretroviral Therapy) status was not recorded.
- Women who had not started ART.
- Sub-study 2 (qualitative):
- Inclusion Criteria:
- AGYW living with HIV who are currently pregnant, previously pregnant/postpartum, and never pregnant).
- HCPs (Health Care Providers) at clinics providing PMTCT services.
- Spouses/partners/parents of AGYW and community stakeholders within the study setting.
- Exclusion criteria
- Mentally or severely ill individuals unable to participate in the study activities.
- Sub-study 3 (co-production)
- Inclusion criteria:
- AGYW, HCPs, spouses/partners, parents, and community stakeholders who participated in the qualitative study II.
- Research team members.
- Exclusion criteria:
- Mentally or severely ill individuals unable to participate in the study activities.
- Sub-study 4 (cluster-randomized implementation trial)
- Inclusion criteria:
- Pregnant AGYW living with HIV (new, previously diagnosed, and transfers) receiving vertical HIV prevention services in routine healthcare between January 1, 2026, and June 30, 2026, and followed up for at least one year until June 30, 2027.
- Exclusion criteria:
- AGYW whose ART (Antiretroviral Therapy) status was not recorded.
Where it is running
- Management and Development for Health — Dar es Salaam, Tanzania (enrolling)
- Management and Development for Health — Kagera, Tanzania (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.